With a revenue increase of 26.47% in the third quarter 2026, year on year to cumulative value of $324 million, Vericel's revenue per employee grew on a trailing twelve months basis to $ 814,500. The productivity of Vericel's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 114 other companies have achieved higher revenue per employee. While Vericel's total ranking has deteriorated compared to the previous quarter from 784 to 1161. Vericel has 398 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VCEL Revenue per Employee	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Revenue Change	26.47 %	22.48 %	30.09 %	23.27 %	16.58 %
Sales per Employee (TTM) $	814,500	769,606	733,884	694,118	650,043
VCEL's Total Ranking	# 1161	# 784	# 720	# 1086	#
Seq. Revenue Change	10.22 %	13.2 %	-26.36 %	37.65 %	6.74 %

VCEL Company Profile >> Back to VCEL Efficiency Comparisons >> Compare VCEL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 20
Healthcare Sector	# 115
Overall Market	# 1161

Revenue per Employee Statistics
High	Average	Low
$ 769,606	$ 346,963	$ 99,611
(Jun 30 2026)		(Mar 31 2015)

Financial Statements
Vericel's Revenue MRQ	$ 85 Millions	Visit VCEL's Income Statement
Vericel's Revenues TTM	$ 324 Millions	Visit VCEL's aggregate revenue growth
What are VCEL's Sales?		Visit VCEL's Sales by Segment

Other Ratios
Vericel's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VCEL's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VCEL's Competitors
Revenue per Employee for VCEL's Suppliers
Revenue per Employee for VCEL's Customers

You may also want to know
VCEL's Sales Growth Rates	VCEL's Pe Price to earnings ratio	VCEL's Receivables Turnover Ratio	VCEL's Stock Quote
VCEL's Net Income Growth Rates	VCEL's Ps Price to Sales ratio	VCEL's Sales per Employee	VCEL's Asset Turnover Ratio
VCEL's Net Margin	VCEL's Pb Price to Book ratio	VCEL's Financial Strength Ratios	VCEL's Dividend Payout Ratio

Date modified: 2026-11-06T12:54:23+00:00

Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Sep 30 2026	Number of Employees Sep 30 2026
Indivior Pharmaceuticals Inc	1,376,000.00	$ 1,376.000 Million	1,000
Biogen Inc	1,372,973.33	$ 10,297.300 Million	7,500
Supernus Pharmaceuticals inc	1,326,849.69	$ 865.106 Million	652
Corcept Therapeutics Inc	1,320,064.38	$ 963.647 Million	730
Travere Therapeutics Inc	1,309,927.57	$ 651.034 Million	497
Lantheus Holdings Inc	1,309,212.07	$ 1,561.890 Million	1,193
Ptc Therapeutics inc	1,166,048.44	$ 1,155.554 Million	991
Abbvie Inc	1,158,140.35	$ 66,014.000 Million	57,000
Biomarin Pharmaceutical Inc	1,134,780.19	$ 3,655.127 Million	3,221
Bridgebio Pharma Inc	1,126,984.51	$ 945.540 Million	839
Arvinas Inc	1,119,105.69	$ 275.300 Million	246
Regeneron Pharmaceuticals Inc	1,096,443.87	$ 16,896.200 Million	15,410
Ani Pharmaceuticals Inc	1,073,549.48	$ 1,041.343 Million	970
Verastem Inc	983,294.12	$ 100.296 Million	102
Syndax Pharmaceuticals Inc	971,244.97	$ 289.431 Million	298
Ardelyx inc	957,505.11	$ 468.220 Million	489
Axsome Therapeutics Inc	935,424.86	$ 865.268 Million	925
Alphatec Holdings Inc	919,662.65	$ 839.652 Million	913
Insmed Inc	888,846.15	$ 1,479.040 Million	1,664
Carlisle Companies Incorporated	883,644.07	$ 5,213.500 Million	5,900
Alkermes Plc	855,414.15	$ 1,753.599 Million	2,050
Pfizer Inc	848,333.33	$ 63,625.000 Million	75,000
Transmedics Group Inc	810,300.67	$ 727.650 Million	898
Cerus Corporation	787,493.06	$ 226.798 Million	288
Ars Pharmaceuticals Inc	749,300.61	$ 122.136 Million	163
Phathom Pharmaceuticals Inc	740,919.14	$ 274.881 Million	371
Emergent Biosolutions Inc	721,222.22	$ 649.100 Million	900
Intuitive Surgical Inc	711,803.07	$ 12,115.600 Million	17,021
Johnson and Johnson	705,504.26	$ 99,335.000 Million	140,800
Mannkind Corporation	698,260.14	$ 413.370 Million	592

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.